Cholinergic receptors on the nematode pharynx: an unexploited drug target
Cholinergic receptors on the nematode pharynx: an unexploited drug target
批准号:
8303109
负责人:
Alan P Robertson
金额:
$18.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-17 至 2014-06-30
关键词:
AdultAffectAgeAnimalsAnthelminticsAscariasisAscarisAscaris suumChildCholinergic ReceptorsDevelopmentDiseaseDrosophila acetylcholine receptor alpha-subunitDrug Delivery SystemsDrug resistanceDrug usageGenesGoalsGrowthHelminthiasisHookwormsHourHumanInfantInfectionIntegral Membrane ProteinIntestinesIon ChannelLeadLevamisoleLibrariesLifeMethodsMuscleNematodaNicotinic ReceptorsOocytesParalysedParasite ControlParasitesParasitic infectionParasitic nematodePatch-Clamp TechniquesPharmaceutical PreparationsPharmacologyPharyngeal structurePopulationPropertyProtein SubunitsPyrantelReportingResearchResistanceResistance developmentScreening procedureSiteSoilTestingTrichurisTrichuris trichiura infectionTropical DiseaseVeterinary MedicineWorkXenopus laevisXenopus oocyteavermectinchemotherapycholinergicdrug discoveryin vivointerestmanneglectnovelnovel therapeutic interventionreceptorreceptor functionreconstitutionresponsespastic paralysisvoltage/patch clamp
中文摘要
描述(申请人提供):被忽视的热带疾病(NTDS)包括土壤传播的蠕虫硫酶(STH),它是由不同的肠道线虫群引起的。这些寄生虫包括蛔虫、鞭虫和钩虫。这些感染很常见。例如,蛔虫病影响着全世界14亿人,最常见的是3至8岁的儿童。这些线虫寄生虫的控制依赖于有效的驱虫剂供应。以兽医为例,我们知道继续使用驱虫药进行大规模化疗会导致耐药性。有必要确定驱虫药开发的新靶点。这样的位置曾经是线虫咽部的烟碱型乙酰胆碱受体。我们发现,这种受体对目前使用的抗虫药物不起作用。方法:本研究的具体目的是:1.利用电流、电压和膜片钳技术研究猪鼻咽肌细胞的nAChR反应。我们将检验这一假设,即猪咽曲霉的nAChRs与胆碱能驱虫药激活的肌肉nAChRs在药理上是不同的。2.鉴定和克隆咽特异性烟碱型乙酰胆碱受体亚基。我们将确定咽部存在的nAChR亚单位基因,这是产生功能性受体所必需的。3.用电压-膜片钳技术研究非洲爪哇卵母细胞咽胆碱能受体的特性。我们将验证这样一种假设,即咽部nAChR亚单位的表达导致功能受体的功能与体内发现的受体在药理上相似。在这个项目完成后,我们将描述寄生线虫中一种重要的潜在药物靶标的药理学特征。我们将识别出编码这些受体的基因。最后,我们将在一个可接近的平台上重组受体,适合于筛选潜在的新驱虫剂。这项研究的长期目标是在一个适合于药物发现筛选的平台(非洲爪哇卵母细胞)上提供一系列重要寄生虫物种的离子通道药物靶点。
英文摘要
DESCRIPTION (provided by applicant): The Neglected Tropical Diseases (NTDs) include the soil-transmitted helminthiases (STHs) which are caused by diverse groups of intestinal nematodes. The parasites include Ascaris, Trichuris and hookworms. These infections are common. Ascariasis for example, affects 1.4 billion people worldwide and is most common in children between the ages of 3 and 8. Control of these nematode parasites relies on an effective supply of anthelmintics. Taking veterinary medicine as an example, we know that continued use of anthelmintic compounds for mass chemotherapy will lead to drug resistance. There is a need to identify novel target sites for anthelmintic development. Once such site is the nicotinic acetylcholine receptor on the nematode pharynx. We have discovered this receptor does not respond to currently used anrthelmintic drugs. Approach: The specific aims of this application are: 1. Characterize nAChR responses in A. suum pharynx: using current-, voltage- & patch- clamp techniques. We will test the hypothesis that the A. suum pharynx nAChRs are pharmacologically distinct from the muscle nAChRs activated by cholinergic anthelmintics. 2. Identify & clone pharyngeal specific nicotinic acetylcholine receptor subunits. We will identify the nAChR subunit genes present in the pharynx required to produce functional receptors. 3. Characterize the pharyngeal cholinergic receptors in Xenopus laevis oocytes using voltage- & patch-clamp techniques. We will test the hypothesis that expression of pharyngeal nAChR subunits results in functioning receptors that are pharmacologically similar to those found in vivo. On completion of this project we will have characterized the pharmacology of an important new potential drug target in a parasitic nematode. We will have identified the genes that encode these receptors. Finally, we will have reconstituted the receptors in an accessible platform suitable for screening potential new anthelmintics. The longer term goal of this research is provide ion- channel drug targets from a range of important parasite species in a platform (Xenopus oocytes) suitable for drug discovery screening.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Eating worms: an unusual nicotinic acetylcholine receptor from the nematode pharynx as a potential drug target
-
批准号:9018496
-
项目类别:
-
资助金额:$21.04万
-
财政年份:2016
-
负责人:Alan P Robertson
-
依托单位:
Eating worms: an unusual nicotinic acetylcholine receptor from the nematode pharynx as a potential drug target
-
批准号:9203615
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2016
-
负责人:Alan P Robertson
-
依托单位:
Cholinergic receptors on the nematode pharynx: an unexploited drug target
-
批准号:8191307
-
项目类别:
-
资助金额:$23.2万
-
财政年份:2011
-
负责人:Alan P Robertson
-
依托单位:
海外基金